Notably, SLC9C1 mutations were predicted to have low functional impact, thus likely represent passenger mutations, yet SLC9C1 was the most abundantly mutated ABT-SLC pan-cancer (Fig. 1b) and in UCEC (Fig. 2b). This evidence concerns the gene CCL21 and cancer.